Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.045 USD | -3.08% | -5.76% | -38.59% |
May. 13 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
May. 09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
COHERUS BIOSCIENCES, INC. | Bio Therapeutic Drugs | -3.08% | -5.76% | -38.59% | -55.15% | -89.96% | 242M |
Technical Rankings Surperformance
- Stock Market
- Equities
- CHRS Stock
- Charts Coherus BioSciences, Inc.
- Comparison Chart